Hims & Hers (HIMS) CTO Mohamed Elshenawy Sells 7,954 Shares

What Happened
Mohamed Elshenawy, CTO of Hims & Hers Health, Inc. (HIMS), reported a sale of 7,954 shares on September 15, 2026. The shares were disposed at $28.39 each, netting approximately $225,814. The filing lists the transaction as an open-market or private sale (code S). Sales are often routine and, unlike purchases, do not by themselves indicate a bullish insider signal.

Key Details

• Transaction date: 2026-09-15; Price: $28.39 per share; Shares sold: 7,954; Total value: ~$225,814.
• Report filed with SEC on 2026-09-17 — appears timely (within the standard two business days).
• Shares owned after the transaction: Not disclosed in the provided Form 4.
• Footnote: The sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2025 (prearranged plan).

Context

• A 10b5-1 plan means the trades were pre-scheduled under a written plan, which reduces the likelihood the sale was based on material nonpublic information.
• Because this is a sale (not a purchase or exercise), it’s typically seen as routine liquidity rather than a direct signal about the company’s prospects.